医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEWS > Home > > 疾病 > AIDS >

China, Share All COVID-19 Data, says AHF

2023年04月01日 AM06:23
このエントリーをはてなブックマークに追加


 

LOS ANGELES

After it was reported that Chinese researchers released “a trove of new genetic data” that can potentially help discern the origin of the COVID-19 pandemic, AIDS Healthcare Foundation (AHF) expressed that while it is a step in the right direction, a full investigation cannot be conducted until China releases all available data it has related to SARS-CoV-2.

“We’re glad that scientists from China’s CDC released this new batch of data that will allow researchers from countries worldwide to analyze for clues on what could’ve started the pandemic,” said AHF Director of Global Advocacy and Policy Guillermina Alaniz. “That said, we’ve had three years of China’s lack of transparency and unwillingness to cooperate by its refusal to grant investigators access to all the information that could determine how the outbreak began. We hope this leads to China uploading more of its data onto platforms like GISAID, which will foster true transparency and cooperation – aspects global public health needed profoundly throughout the pandemic yet didn’t get.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230331005436/en/

CONTACT

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work +1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

同じカテゴリーの記事 

  • QPSホールディングス、神経薬理事業部門を売却
  • Fujirebio和Sysmex通过免疫测定合作将CDMO伙伴关系扩展到神经退行性疾病领域
  • Freudenberg Medical Showcases Innovations and Expansion News at CPhI & PMEC India
  • リバルブ・ソリューションズ、ヒトで初めて次世代TMVR技術に成功したと発表
  • ReValve Solutions宣布其新一代经导管二尖瓣置换术(TMVR)技术首次成功应用于人体